Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 6 | 2022 | 425 | 0.950 |
Why?
|
| Thyroxine | 9 | 2019 | 355 | 0.810 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 206 | 0.580 |
Why?
|
| Pituitary Neoplasms | 2 | 2007 | 69 | 0.510 |
Why?
|
| Carcinoma, Papillary | 2 | 2018 | 156 | 0.510 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2022 | 147 | 0.460 |
Why?
|
| Adenoma | 2 | 2006 | 250 | 0.380 |
Why?
|
| Iodine Radioisotopes | 2 | 2001 | 134 | 0.370 |
Why?
|
| Thyroxine-Binding Proteins | 9 | 1992 | 86 | 0.370 |
Why?
|
| Thyroid Nodule | 2 | 2022 | 62 | 0.360 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2008 | 8 | 0.310 |
Why?
|
| Electronic Prescribing | 1 | 2008 | 11 | 0.310 |
Why?
|
| Medical Order Entry Systems | 1 | 2008 | 27 | 0.310 |
Why?
|
| Medication Errors | 1 | 2008 | 39 | 0.300 |
Why?
|
| Safety Management | 1 | 2008 | 56 | 0.300 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 1066 | 0.300 |
Why?
|
| Triiodothyronine | 9 | 2001 | 346 | 0.290 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2008 | 102 | 0.290 |
Why?
|
| Hyperprolactinemia | 1 | 2007 | 5 | 0.280 |
Why?
|
| Hyperthyroidism | 5 | 2001 | 75 | 0.280 |
Why?
|
| Prolactinoma | 1 | 2007 | 8 | 0.280 |
Why?
|
| Testosterone | 3 | 2007 | 272 | 0.280 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 225 | 0.270 |
Why?
|
| Thyrotropin | 7 | 1994 | 289 | 0.270 |
Why?
|
| Progestins | 1 | 2006 | 22 | 0.260 |
Why?
|
| Plasmacytoma | 1 | 2006 | 34 | 0.260 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2005 | 109 | 0.250 |
Why?
|
| Contraception | 1 | 2006 | 93 | 0.240 |
Why?
|
| Bone Density | 1 | 2006 | 211 | 0.240 |
Why?
|
| Erectile Dysfunction | 1 | 2004 | 76 | 0.230 |
Why?
|
| Hypothyroidism | 5 | 2003 | 243 | 0.220 |
Why?
|
| Mutation | 3 | 2018 | 4165 | 0.210 |
Why?
|
| Weight Loss | 1 | 2004 | 233 | 0.210 |
Why?
|
| Goiter, Nodular | 1 | 2001 | 7 | 0.190 |
Why?
|
| Parathyroid Neoplasms | 1 | 2001 | 60 | 0.190 |
Why?
|
| Thyroid Diseases | 3 | 1989 | 105 | 0.170 |
Why?
|
| Thyroid Hormones | 4 | 2003 | 330 | 0.170 |
Why?
|
| Endocrinology | 1 | 2020 | 49 | 0.160 |
Why?
|
| Prolactin | 2 | 2007 | 89 | 0.160 |
Why?
|
| Humans | 32 | 2022 | 89925 | 0.150 |
Why?
|
| Obesity | 1 | 2004 | 972 | 0.150 |
Why?
|
| Female | 18 | 2020 | 46572 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2022 | 556 | 0.150 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 103 | 0.140 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2018 | 55 | 0.140 |
Why?
|
| Nuclear Reactors | 1 | 1996 | 7 | 0.130 |
Why?
|
| Radioactive Hazard Release | 1 | 1996 | 8 | 0.130 |
Why?
|
| Hyperostosis Frontalis Interna | 1 | 2014 | 4 | 0.120 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2014 | 69 | 0.110 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2022 | 107 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1054 | 0.100 |
Why?
|
| Adult | 15 | 2020 | 26811 | 0.100 |
Why?
|
| Liver | 2 | 1988 | 1211 | 0.100 |
Why?
|
| Male | 16 | 2020 | 42658 | 0.100 |
Why?
|
| Thyroid Function Tests | 3 | 1994 | 120 | 0.090 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1990 | 40 | 0.090 |
Why?
|
| Neoplasms | 1 | 2005 | 3065 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 414 | 0.090 |
Why?
|
| Hyperthyroxinemia | 1 | 1988 | 17 | 0.080 |
Why?
|
| Medication Systems, Hospital | 1 | 2008 | 7 | 0.080 |
Why?
|
| Thyroid Crisis | 1 | 1988 | 3 | 0.080 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 1988 | 20 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 40 | 0.080 |
Why?
|
| Parathyroidectomy | 2 | 2014 | 80 | 0.070 |
Why?
|
| Documentation | 1 | 2008 | 103 | 0.070 |
Why?
|
| Ergolines | 1 | 2007 | 8 | 0.070 |
Why?
|
| Bromocriptine | 1 | 2007 | 12 | 0.070 |
Why?
|
| Dopamine Agonists | 1 | 2007 | 27 | 0.070 |
Why?
|
| Drug Implants | 1 | 2006 | 34 | 0.070 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2006 | 21 | 0.070 |
Why?
|
| Diabetes Insipidus | 1 | 2006 | 17 | 0.070 |
Why?
|
| Bone Resorption | 1 | 2006 | 42 | 0.070 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2006 | 12 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 110 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 1607 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2005 | 230 | 0.060 |
Why?
|
| Middle Aged | 8 | 2020 | 26133 | 0.060 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 1995 | 160 | 0.060 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 2 | 1995 | 117 | 0.060 |
Why?
|
| Blood Protein Disorders | 1 | 1983 | 8 | 0.060 |
Why?
|
| Alpha-Globulins | 1 | 1983 | 11 | 0.060 |
Why?
|
| Thyroglobulin | 1 | 1983 | 59 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2005 | 328 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2005 | 720 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2003 | 86 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 1929 | 0.050 |
Why?
|
| Antithyroid Agents | 1 | 2001 | 23 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 1469 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 1880 | 0.050 |
Why?
|
| Physicians | 1 | 2008 | 691 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2001 | 171 | 0.040 |
Why?
|
| Adolescent | 4 | 2006 | 9339 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2001 | 666 | 0.040 |
Why?
|
| Radioimmunoassay | 3 | 1989 | 155 | 0.040 |
Why?
|
| Drug Resistance | 2 | 1990 | 232 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2014 | 8270 | 0.040 |
Why?
|
| Health Policy | 1 | 2020 | 188 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 74 | 0.040 |
Why?
|
| Aged | 5 | 2001 | 19241 | 0.040 |
Why?
|
| Ukraine | 1 | 1996 | 20 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 495 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1996 | 189 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 270 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 584 | 0.030 |
Why?
|
| Oncogenes | 1 | 1996 | 97 | 0.030 |
Why?
|
| Reference Values | 2 | 1988 | 662 | 0.030 |
Why?
|
| Surgeons | 1 | 2020 | 249 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2006 | 2314 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 1996 | 173 | 0.030 |
Why?
|
| Risk Factors | 1 | 2005 | 5555 | 0.030 |
Why?
|
| Child, Preschool | 3 | 1995 | 3769 | 0.030 |
Why?
|
| Thymectomy | 1 | 2014 | 31 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 3470 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2014 | 69 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1729 | 0.030 |
Why?
|
| Cell Line | 3 | 1988 | 2495 | 0.030 |
Why?
|
| Proline | 1 | 1994 | 55 | 0.030 |
Why?
|
| Serine | 1 | 1994 | 105 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 220 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1533 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 9203 | 0.030 |
Why?
|
| Point Mutation | 1 | 1994 | 245 | 0.030 |
Why?
|
| Child | 4 | 1995 | 7242 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1988 | 399 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2653 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2014 | 337 | 0.020 |
Why?
|
| United States | 2 | 2020 | 7102 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1227 | 0.020 |
Why?
|
| Pedigree | 2 | 1994 | 971 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 1988 | 755 | 0.020 |
Why?
|
| Thyrotoxicosis | 1 | 1988 | 18 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 1989 | 38 | 0.020 |
Why?
|
| Immunoassay | 1 | 1989 | 91 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1859 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 865 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1988 | 128 | 0.020 |
Why?
|
| Animals | 3 | 2001 | 27526 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 3680 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1988 | 591 | 0.020 |
Why?
|
| Estradiol | 1 | 1988 | 250 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 2327 | 0.020 |
Why?
|
| Dialysis | 1 | 1985 | 24 | 0.020 |
Why?
|
| Base Sequence | 3 | 1995 | 2329 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1992 | 1380 | 0.020 |
Why?
|
| Rats | 2 | 1989 | 4048 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 1995 | 3024 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2677 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1989 | 1731 | 0.010 |
Why?
|
| Infant | 1 | 1990 | 3189 | 0.010 |
Why?
|
| X Chromosome | 1 | 1983 | 153 | 0.010 |
Why?
|
| Heterozygote | 1 | 1983 | 373 | 0.010 |
Why?
|
| Protein Denaturation | 3 | 1988 | 106 | 0.010 |
Why?
|
| Hot Temperature | 3 | 1988 | 207 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 6780 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 39 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1995 | 146 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1995 | 182 | 0.010 |
Why?
|
| Introns | 1 | 1992 | 301 | 0.010 |
Why?
|
| Exons | 1 | 1992 | 453 | 0.010 |
Why?
|
| Genotype | 1 | 1994 | 1853 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2063 | 0.000 |
Why?
|
| Phenolsulfonphthalein | 1 | 1988 | 3 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1988 | 52 | 0.000 |
Why?
|
| Blood | 1 | 1988 | 69 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 312 | 0.000 |
Why?
|
| DNA | 1 | 1994 | 1311 | 0.000 |
Why?
|
| Phenotype | 1 | 1994 | 2457 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 1048 | 0.000 |
Why?
|
| Receptors, Estrogen | 1 | 1988 | 394 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1988 | 602 | 0.000 |
Why?
|
| Isoelectric Focusing | 1 | 1985 | 39 | 0.000 |
Why?
|
| Immunochemistry | 1 | 1985 | 16 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 269 | 0.000 |
Why?
|
| Myocardial Contraction | 1 | 1986 | 252 | 0.000 |
Why?
|
| Heart Rate | 1 | 1986 | 498 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1986 | 479 | 0.000 |
Why?
|
| Kinetics | 1 | 1985 | 1534 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1988 | 2026 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1986 | 786 | 0.000 |
Why?
|
| Pregnancy | 1 | 1988 | 3040 | 0.000 |
Why?
|